Reuters logo
REFILE-Mallinckrodt settles U.S. opioid drug probe for $35 million
2017年7月11日 / 晚上7点05分 / 2 个月前

REFILE-Mallinckrodt settles U.S. opioid drug probe for $35 million

(Refiles to fix slug)

July 11 (Reuters) - Mallinckrodt Plc, one of the largest manufacturers of the generic opioid painkiller oxycodone, will pay $35 million to resolve allegations that the company failed to report suspicious drug orders, the U.S. Justice Department said on Tuesday.

The deal marked a record settlement of claims that a drugmaker failed to properly notify the U.S. Drug Enforcement Administration of suspicious orders for drugs such as oxycodone, the Justice Department said. (Reporting by Nate Raymond in Boston; Editing by Lisa Shumaker)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below